Published in J Virol on July 01, 1996
Integration-deficient lentiviral vectors: a slow coming of age. Mol Ther (2009) 1.47
Structural biology of retroviral DNA integration. Virology (2011) 1.37
Retroviral integrase proteins and HIV-1 DNA integration. J Biol Chem (2012) 1.20
Ebola virus VP30 is an RNA binding protein. J Virol (2007) 1.04
Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins. J Virol (2006) 1.03
Lys-34, dispensable for integrase catalysis, is required for preintegration complex function and human immunodeficiency virus type 1 replication. J Virol (2005) 1.01
Molecular mechanisms of retroviral integration site selection. Nucleic Acids Res (2014) 1.01
Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction. Nucleic Acids Res (2014) 1.00
A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses. EMBO J (2003) 0.91
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements. Mol Ther Nucleic Acids (2014) 0.91
Retroviral DNA Integration. Chem Rev (2016) 0.90
Assembly and catalysis of concerted two-end integration events by Moloney murine leukemia virus integrase. J Virol (2001) 0.88
Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection. J Virol (2002) 0.84
Retroviral Integrase Structure and DNA Recombination Mechanism. Microbiol Spectr (2015) 0.83
Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication. Antimicrob Agents Chemother (2008) 0.83
Implication of a central cysteine residue and the HHCC domain of Moloney murine leukemia virus integrase protein in functional multimerization. J Virol (1998) 0.82
Functional interactions of the HHCC domain of moloney murine leukemia virus integrase revealed by nonoverlapping complementation and zinc-dependent dimerization. J Virol (1999) 0.82
Structural and sequencing analysis of local target DNA recognition by MLV integrase. Nucleic Acids Res (2015) 0.82
A chimeric Ty3/Moloney murine leukemia virus integrase protein is active in vivo. J Virol (1998) 0.81
The GP(Y/F) domain of TF1 integrase multimerizes when present in a fragment, and substitutions in this domain reduce enzymatic activity of the full-length protein. J Biol Chem (2008) 0.80
Structural and functional insights into foamy viral integrase. Viruses (2013) 0.76
Retroviral integrase protein and intasome nucleoprotein complex structures. World J Biol Chem (2017) 0.75
X-ray Crystal Structure of the N-Terminal Region of Moloney Murine Leukemia Virus Integrase and its Implications for Viral DNA Recognition. Proteins (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci U S A (1979) 27.20
Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82
A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev (1989) 8.80
The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell (1990) 7.99
Integration of murine leukemia virus DNA depends on mitosis. EMBO J (1993) 7.62
Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc Natl Acad Sci U S A (1986) 6.94
The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J Virol (1989) 6.83
Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol (1992) 6.77
HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell (1991) 6.54
Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol (1992) 6.07
Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence. Cell (1989) 6.04
Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol (1990) 5.81
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol (1991) 5.49
Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science (1992) 4.97
Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J (1993) 4.39
Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res (1991) 4.39
The retroviral enzymes. Annu Rev Biochem (1994) 4.21
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A (1993) 3.99
Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell (1985) 3.81
Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc Natl Acad Sci U S A (1992) 3.55
Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res (1993) 3.42
Complementation between HIV integrase proteins mutated in different domains. EMBO J (1993) 3.32
Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res (1991) 2.93
DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2. Nucleic Acids Res (1991) 2.74
Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J Biol Chem (1993) 2.69
A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J Virol (1992) 2.18
Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res (1994) 1.98
Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein. AIDS Res Hum Retroviruses (1992) 1.82
Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis. Nucleic Acids Res (1993) 1.79
Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting. J Virol (1990) 1.75
An essential interaction between distinct domains of HIV-1 integrase mediates assembly of the active multimer. J Biol Chem (1995) 1.67
Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J Virol (1992) 1.64
Analysis of mutant Moloney murine leukemia viruses containing linker insertion mutations in the 3' region of pol. J Virol (1988) 1.63
Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis. J Virol (1991) 1.62
Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli. J Biol Chem (1993) 1.44
Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase. Nucleic Acids Res (1994) 1.29
Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J Virol (1993) 1.25
Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J Virol (1991) 1.21
DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. J Virol (1994) 1.15
Mutational analysis of the sequences at the termini of the Moloney murine leukemia virus DNA required for integration. Virology (1993) 1.12
Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase. J Virol (1994) 1.08
Characterization of recombinant murine leukemia virus integrase. J Virol (1995) 1.03
Rous sarcoma virus integrase protein: mapping functions for catalysis and substrate binding. J Virol (1994) 1.03
Influence of substrate structure on disintegration activity of Moloney murine leukemia virus integrase. J Virol (1993) 0.97
Analysis of a temperature-sensitive mutation affecting the integration protein of Moloney murine leukemia virus. Virology (1993) 0.81
Secondary structural analysis of retrovirus integrase: characterization by circular dichroism and empirical prediction methods. Proteins (1989) 0.80
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 4.40
Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer (1998) 2.39
Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut (2005) 2.31
Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood (1996) 2.21
A small nucleolar RNA requirement for site-specific ribose methylation of rRNA in Xenopus. Proc Natl Acad Sci U S A (1996) 2.18
Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli. J Virol (1986) 2.18
A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol (1982) 2.17
Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol (1993) 2.08
Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J Biol Chem (1985) 2.02
The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol (2005) 2.01
Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet (1998) 1.83
Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1. J Virol (1990) 1.80
Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol (2001) 1.70
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Neurological complications of celiac disease: a rare but continuing problem. Am J Gastroenterol (1996) 1.68
Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J Virol (1992) 1.64
Childhood empyema. Thorax (1999) 1.55
The division of neuronal progenitor cells during migration in the neonatal mammalian forebrain. Mol Cell Neurosci (1995) 1.53
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res (2000) 1.50
Clearing of melanoma in situ with intralesional interferon alfa in a patient with xeroderma pigmentosum. Arch Dermatol (1994) 1.46
Haemorrheological alterations associated with competitive racing activity in horses: implications for exercise-induced pulmonary haemorrhage (EIPH) Equine Vet J (1998) 1.46
Survival and settlement success of coral planulae: independent and synergistic effects of macroalgae and microbes. Oecologia (2008) 1.46
Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli. J Biol Chem (1993) 1.44
Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3). J Biol Chem (1992) 1.44
Chemically defined medium for oral microorganisms. J Clin Microbiol (1985) 1.43
CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol (1996) 1.42
Histocompatibility requirements for T cell help in specific in vitro antibody responses to influenza virus by human blood lymphocytes. Eur J Immunol (1981) 1.41
Effects of Salinity on Primary Processes of Photosynthesis in the Red Alga Porphyra perforata. Plant Physiol (1983) 1.41
Analysis of bacteriophage phi X174 gene A protein-mediated termination and reinitiation of phi X DNA synthesis. II. Structural characterization of the covalent phi X A protein-DNA complex. J Biol Chem (1984) 1.41
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol (1994) 1.36
Unusual phenotype and function of an expanded subpopulation of T cells in patients with haemopoietic disorders. Clin Exp Immunol (1981) 1.35
MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg (2010) 1.34
Regulation of mitochondrial alpha-ketoglutarate metabolism by product inhibition at alpha-ketoglutarate dehydrogenase. J Biol Chem (1974) 1.33
Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut (2005) 1.32
The effect of transfer to a warm environment (30 degree C.) on the metabolic response to injury. Br J Surg (1968) 1.31
High levels of carcinogenic polycyclic aromatic hydrocarbons present within food from Linxian, China may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer (1998) 1.30
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. JAMA (1998) 1.27
Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology (2001) 1.26
Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr (1982) 1.26
RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases. Virology (1997) 1.25
Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J Virol (1993) 1.25
Clinical and microbiological features of refractory periodontitis subjects. J Clin Periodontol (1998) 1.25
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis (2007) 1.23
Studies of esophageal balloon cytology in Linxian, China. Cancer Epidemiol Biomarkers Prev (1997) 1.23
Influence of focal growth conditions on the pathogenesis of toxic shock syndrome. J Infect Dis (1987) 1.23
The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis (1991) 1.22
New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. J Med Chem (1998) 1.21
Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1994) 1.21
Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin Cancer Res (1999) 1.20
Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain. J Virol (1993) 1.19
Rapid method for the purification of DNA from subgingival microorganisms. Oral Microbiol Immunol (1989) 1.19
Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer (2000) 1.19
Treatment of haemangioendotheliomas with alpha interferon. Lancet (1989) 1.15
Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res (2001) 1.14
Prolonged hyporesponsiveness of vascular smooth muscle contraction after halothane anesthesia in rabbits. Anesth Analg (1985) 1.13
Activities of NAD-specific and NADP-specific isocitrate dehydrogenases in rat-liver mitochondria. Studies with D-threo-alpha-methylisocitrate. Eur J Biochem (1979) 1.12
Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol (2003) 1.12
Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis. Health Technol Assess (2004) 1.11
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol (1999) 1.09
Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J Virol (2000) 1.09
Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol. Symp Soc Exp Biol (1973) 1.09
Failure of exogenous gonadotrophin controlled ovulation to cause digit abnormalities in mice. Nature (1975) 1.08
Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase. Biochemistry (1995) 1.07
Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J Virol (1996) 1.07
Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J Clin Microbiol (1991) 1.06
The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review. Injury (2008) 1.06
Biosynthesis of water-soluble vitamins. Annu Rev Biochem (1974) 1.06
Characterization of the major DNA repair methyltransferase activity in unadapted Escherichia coli and identification of a similar activity in Salmonella typhimurium. J Bacteriol (1989) 1.04
A micromethod for the induction and assay of specific in vitro antibody responses by human lymphocytes. J Immunol Methods (1981) 1.04
Chin morphology and sexual dimorphism in the fossil hominid mandible sample from Klasies River Mouth. Am J Phys Anthropol (1996) 1.04
Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus. Virology (1995) 1.03
Control of the transport of reducing equivalents across the mitochondrial membrane in perfused rat heart. J Mol Cell Cardiol (1971) 1.03
Exercise-induced asthma: a difference in opinion regarding the stimulus. Allergy Proc (1989) 1.02
Abnormal oesophageal motility in patients with chronic cough. Thorax (2003) 1.02
A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection. FEBS Lett (2001) 1.02
Medication compliance and substance abuse among schizophrenic patients. Hosp Community Psychiatry (1990) 1.01
High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China. Carcinogenesis (2000) 1.01
RNA capping by the vaccinia virus guanylyltransferase. Structure of enzyme-guanylate intermediate. J Biol Chem (1984) 1.00
Phenotype of human T helper and suppressor cells in an in vitro specific antibody response. Eur J Immunol (1982) 0.99
Polycyclic aromatic hydrocarbons identified in soot extracts from domestic coal-burning stoves of Henan Province, China. Environ Sci Technol (2001) 0.99
Metabolism after injury. I. Effects of severity, nutrition, and environmental temperatue on protein potassium, zinc, and creatine. Br J Surg (1972) 0.97
Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res (1999) 0.97
RNase H requirements for the second strand transfer reaction of human immunodeficiency virus type 1 reverse transcription. J Virol (1999) 0.97
Influence of substrate structure on disintegration activity of Moloney murine leukemia virus integrase. J Virol (1993) 0.97
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses (1997) 0.96
Hyperosmolarity as the stimulus to asthma induced by hyperventilation? J Allergy Clin Immunol (1986) 0.95
Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (1996) 0.94
The relationship between metabolic state and total CoA content of rat liver and heart. J Nutr (1978) 0.94
Enumeration of subgingival species on primary isolation plates using colony lifts. Oral Microbiol Immunol (1992) 0.94
Signs and symptoms of hangover: prevalence and relationship to alcohol use in a general adult population. Drug Alcohol Depend (1983) 0.94
The peptide hormone pQDLDHVFLRFamide (crustacean myosuppressin) modulates the Homarus americanus cardiac neuromuscular system at multiple sites. J Exp Biol (2009) 0.94
Sclerodermatous graft-versus-host disease limited to an area of measles exanthem. Lancet (1978) 0.94
Expert variability provides perspective on the strengths and weaknesses of citizen-driven intertidal monitoring program. Ecol Appl (2012) 0.93
The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure. Biochemistry (1976) 0.93
Choline therapy in Alzheimer's disease. Lancet (1978) 0.93
Use of a safety climate questionnaire in UK health care: factor structure, reliability and usability. Qual Saf Health Care (2006) 0.93
Late-form hemorrhagic disease of the newborn: a fatal case report with illustration of investigations that may assist in avoiding the mistaken diagnosis of child abuse. Am J Forensic Med Pathol (1999) 0.93
Inhibitors of inosinate dehydrogenase activity in Ehrlich ascites tumor cells in vitro. Biochem Pharmacol (1974) 0.92
Development of a broth medium for Bacteroides forsythus. J Clin Microbiol (1987) 0.92